Company Analysis

Cytek Biosciences, Inc. (CTKB)

Nasdaq: CTKB · Laboratory Analytical Instruments · Fremont, CA · filing with the SEC since 2020
Grade5.8
◀ Past 7.4● Present 5.8▶ Future 4.1

Who runs Cytek Biosciences, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Jiang Wenbin
PRESIDENT AND CEO. First filing Jul 2021, latest Aug 20, 2026, 22 filings in all.
Officers reporting now
6
of 12 people with a filing in the last fifteen months
Directors reporting now
6
25 people on the record since 2021
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Feuchtwang IlanChief Legal Officer, SecretaryJun 2026Nov 12, 2026none
Jiang WenbinPRESIDENT AND CEOJul 2021Aug 20, 2026none
Mccombe William D.Chief Financial OfficerMar 2024Aug 20, 2026none
Yan MingCHIEF TECHNOLOGY OFFICERJul 2021Aug 20, 2026none
Barnett ValerieCHIEF LEGAL OFFICERJul 2021May 20, 2026none
Busque PhilippeSVP, GLOBAL SALES AND SERVICESAug 2023May 20, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Chin RicharddirectorJun 2025Aug 20, 2026none
Holder MichaeldirectorJun 2024Aug 20, 2026none
Muir Glenn PdirectorJun 2026Aug 20, 2026none
Ball JackdirectorJul 2021Jun 12, 2026none
Imper VeradirectorJan 2022Jun 12, 2026none
Neff Deborah JdirectorJun 2022Jun 12, 2026none
Earlier names on the record13, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CTKB · research, not advice